Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 832-365-4 | CAS number: 1184581-58-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 4-(3,5-dichlorobenzamido)-3-hydroxybenzoic acid
- EC Number:
- 832-365-4
- Cas Number:
- 1184581-58-5
- Molecular formula:
- C14H9Cl2NO4
- IUPAC Name:
- 4-(3,5-dichlorobenzamido)-3-hydroxybenzoic acid
- Test material form:
- solid: particulate/powder
- Details on test material:
- Batch E010014831, re-test date: 30 June 2015
Constituent 1
- Specific details on test material used for the study:
- Description White to off white powder
Batch E010014831
Purity/Composition 99.5%
Test substance storage At room temperature in the dark
Stable under storage conditions until 30 June 2015 (Retest date)
pH (1% in water, indicative range) 5.3 – 5.0 (determined by WIL Research Europe B.V.)
Stability in vehicle:
• N,N-Dimethylformamide Unknown
Solubility in vehicle:
• N,N-Dimethylformamide 172 mg/g
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA:J
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Janvier, Le Genest-Saint-Isle, France
- Females (if applicable) nulliparous and non-pregnant: yes
- Microbiological status of animals, when known:
- Age at study initiation: Young adult animals (approx. 9 weeks old)
- Weight at study initiation: 18-23g Body weight variation was within +/- 20% of the sex mean.
- Housing: Animals were group housed in labeled Makrolon cages (MIII type; height 18 cm) containing sterilised sawdust as bedding material (Lignocel S 8-15, JRS - J.Rettenmaier & Söhne GmbH + CO. KG, Rosenberg, Germany). Paper (Enviro-dri, Wm. Lillico & Son (Wonham Mill Ltd), Surrey, United Kingdom) and shelters (disposable paper corner home, MCORN 404, Datesand Ltd, USA) were supplied as cage-enrichment
- Diet (e.g. ad libitum): Free access to pelleted rodent diet (SM R/M-Z from SSNIFF® Spezialdiäten GmbH, Soest, Germany).
- Water (e.g. ad libitum): Free access to tap water.
- Acclimation period: The acclimatization period was at least 5 days before the start of
treatment under laboratory conditions. On Day 6, the animals were group housed in Makrolon MII type cages with a sheet of paper instead of sawdust and cage enrichment.
- Indication of any skin lesions:
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 to 24°C,
- Humidity (%): 40 to 70%
- Air changes (per hr): at least 10 air changes/hour
- Photoperiod (hrs dark / hrs light): 12-hour light/12-hour dark cycle
- IN-LIFE DATES: From: 19 March 2014 To: 14 April 2014
Study design: in vivo (LLNA)
- Vehicle:
- dimethylformamide
- Concentration:
- Pre-screen 25 and 50% w/v
Main test 0, 10, 25 and 50% w/v - No. of animals per dose:
- 5 (five)
- Details on study design:
- PRE-SCREEN TESTS:
A pre-screen test was conducted in order to select the highest test substance concentration to be used in the main study. In principle, this highest concentration should cause no systemic toxicity, may give well-defined irritation at the most (maximum grade 2 (see section 6.7) and/or an increase in ear thickness < 25%) and is the highest possible concentration that can technically be applied.
Two test substance concentrations were tested; a 25% and 50% concentration. The highest concentration was the maximum concentration as required in the test guidelines (50% for solids).
The test system, procedures and techniques were identical to those used in the main study except that the assessment of lymph node proliferation and necropsy were not performed. Two young adult animals per concentration were selected. Each animal was treated with one concentration on three consecutive days. Animals were group housed in labeled Makrolon cages (MII type, height 14 cm).
Ear thickness measurements were conducted using a digital thickness gauge (Kroeplin C110T-K) prior to dosing on Days 1 and 3, and on Day 6.
Animals were sacrificed after the final observation.
- Compound solubility: 172 mg/g
- Irritation: none noted
- Systemic toxicity: none noted
- Ear thickness measurements: <25% variation from the Day 1 pre-dose values
- Erythema scores: no erythema noted
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: LLNA
- Criteria used to consider a positive response: SI >3
TREATMENT PREPARATION AND ADMINISTRATION:
Three groups of five animals were treated with one test substance concentration per group. The
highest test substance concentration was selected from the pre-screen test.
One group of five animals was treated with vehicle. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
- Positive control results:
- The SI values calculated for the substance concentrations 5, 10 and 25% were 1.2, 1.1 and 8.0
respectively. An EC3 value of 14.1% was calculated using linear interpolation.
The calculated EC3 value was found to be in the acceptable range of 2 and 20%. The results of the 6
monthly HCA reliability checks of the recent years were 11.9, 16.9, 14.4, 16.5, 14.5 and 13.4%.
Based on the results, it was concluded that the Local Lymph Node Assay as performed at WIL
Research Europe is an appropriate model for testing for contact hypersensitivity.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- ca. 1
- Variability:
- SEM 0.2
- Test group / Remarks:
- 0% w/v
- Parameter:
- SI
- Value:
- ca. 1.2
- Variability:
- SEM 0.2
- Test group / Remarks:
- 10% w/v
- Parameter:
- SI
- Value:
- ca. 1.1
- Variability:
- SEM 0.2
- Test group / Remarks:
- 25% w/v
- Parameter:
- SI
- Value:
- ca. 1.1
- Variability:
- SEM 0.2
- Test group / Remarks:
- 50% w/v
- Parameter:
- EC3
- Remarks on result:
- not determinable
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA
- DPM
0% w/v 187 ± 24
10% w/v 224 ± 20
25% w/v 204 ± 34
50% w/v 209 ± 30
DETAILS ON STIMULATION INDEX CALCULATION
A Stimulation Index (SI) is calculated for each group using the individual SI values. The individual SI is the ratio of the DPM/animal compared to DPM/vehicle control group.
EC3 CALCULATION
Not Applicable
CLINICAL OBSERVATIONS:
No irritation of the ears was observed in any of the animals examined. White test substance remnants were present on the dorsal surface of the ears of the experimental animals during the observation period but did not hamper scoring of the skin reactions.
No test substance related mortality occurred and no clinical signs of systemic toxicity were observed in the animals of the main study.
BODY WEIGHTS
Body weights and body weight gain of experimental animals remained
in the same range as controls over the study period.
Any other information on results incl. tables
Macroscopic findings
No abnormalities were found at macroscopic post mortem examination of the anima, which died prior
to 3H-methyl thymidine injection.
Macroscopy of the auricular lymph nodes and surrounding area
All auricular lymph nodes were considered normal in size.
No macroscopic abnormalities of the surrounding area were noted in any of the animals.
Radioactivity measurements and SI values
Mean DPM/animal values for the experimental groups treated with test substance concentrations 10,
25 and 50% were 224, 204 and 209 DPM respectively. The mean DPM/animal value for the vehicle
control group was 187 DPM. The SI values calculated for the substance concentrations 10, 25 and
50% were 1.2, 1.1 and 1.1, respectively.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Since there was no indication that the test substance elicited an SI ≥ 3 when tested up to 50%, PF06410251
was not considered to be a skin sensitizer.
The six-month reliability check with Alpha-hexylcinnamaldehyde indicates that the Local Lymph Node
Assay as performed at WIL Research Europe is an appropriate model for testing for contact
hypersensitivity .
Based on these results, PF-06410251 would not be regarded as a skin sensitizer according to the
recommendations made in the test guidelines. The test substance does not have to be classified and
has no obligatory labelling requirement for sensitization by skin contact according to the Globally
Harmonized System of Classification and Labelling of Chemicals (GHS) of the United Nations (2011)
(including all amendments) and the Regulation (EC) No 1272/2008 on classification, labelling and
packaging of substances and mixtures (including all amendments). - Executive summary:
Assessment of Contact Hypersensitivity to PF-06410251 in the Mouse (Local Lymph Node Assay).
The study was carried out based on the guidelines described in:
OECD, Section 4, Health Effects, No.429 (2010),
EC, No 440/2008; B42: "Skin Sensitization: Local Lymph Node Assay"
EPA, OPPTS 870.2600 (2003) “Skin Sensitization”.
Test substance concentrations selected for the main study were based on the results of a pre-screen
test.
In the main study, three experimental groups of five female CBA/J mice were treated with test
substance concentrations of 10, 25 or 50% w/w on three consecutive days, by open application on the
ears. Five vehicle control animals were similarly treated, but with vehicle alone (Dimethyl formamide).
Three days after the last exposure, the animals were injected with 3H-methyl thymidine and after five
hours the draining (auricular) lymph nodes were excised and pooled for each animal.
After precipitating the DNA of the lymph node cells, radioactivity measurements were performed. The
activity was expressed as the number of Disintegrations Per Minute (DPM) and a stimulation index (SI)
was subsequently calculated for each group.
No irritation of the ears was observed in any of the animals examined.
All auricular lymph nodes were considered normal in size. No macroscopic abnormalities of the
surrounding area were noted in any of the animals.
Mean DPM/animal values for the experimental groups treated with test substance concentrations 10,
25 and 50% were 224, 204 and 209 DPM respectively. The mean DPM/animal value for the vehicle
control group was 187 DPM. The SI values calculated for the substance concentrations 10, 25 and
50% were 1.2, 1.1 and 1.1, respectively.
Since there was no indication that the test substance elicited an SI ≥ 3 when tested up to 50%, PF06410251
was not considered to be a skin sensitizer.
The six-month reliability check with Alpha-hexylcinnamaldehyde indicates that the Local Lymph Node
Assay as performed at WIL Research Europe is an appropriate model for testing for contact
hypersensitivity.
Based on these results, PF-06410251 would not be regarded as a skin sensitizer according to the
recommendations made in the test guidelines. The test substance does not have to be classified and
has no obligatory labelling requirement for sensitization by skin contact according to the Globally
Harmonized System of Classification and Labelling of Chemicals (GHS) of the United Nations (2011)
(including all amendments) and the Regulation (EC) No 1272/2008 on classification, labelling and
packaging of substances and mixtures (including all amendments).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.